Home » Headlines » Currently Reading:

Morning Headlines 5/6/16

May 5, 2016 Headlines 3 Comments

A Deep Dive on the MACRA NPRM

BIDMC CIO John Halamka, MD publishes his analysis of the recently released MACRA proposed rule.

Cerner Reports First Quarter 2016 Results

Cerner reports Q1 results: revenue grew 14 percent to $1.14 billion vs. $996 million during the same quarter last year, adjusted EPS $0.53 vs. $0.45, missing revenue projections. Share prices fell four percent in after hours trading.

Allscripts announces first quarter 2016 results

Allscripts reports Q1 results: revenue grew three percent to $346 million but fell short of projections, adjusted EPS $0.13 vs. $0.08.

Ns1ghter Launches Free and Unlimited Doctor Visits

An Austin-based startup launches offering free, unlimited telehealth visits and free second opinion case reviews.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there are "3 comments" on this Article:

  1. It’s important to point out on a GAAP basis they earned $.01 per share. More interesting than that is their current ratio dipped slightly below 1. Think about this like your house, if your debt repayment for the next 12 months exceed what you have in savings you have a current ratio less than 1.

    More interesting is that they didn’t take a writedown on NantHealth or if they did it was small despite market conditions not favoring an IPO. There business is also shifting from software to services. It’s hard to imagine how they got profitability up in that transition, but more importantly how sustainable that kind of move is going to be for them. Showing an increasing backlog of work is also interesting. Hopefully others know a lot of people buying Allscripts services.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Woodstock Generation: Gotta love those O'Jays, hot pink suits et al. In other words, gotta love doo-wop, soul, and all those related sounds t...
  • Vaporware?: JTR, Cerner is re-tooling itself from a software company (sic) into a service company. The company needs a place to put ...
  • Dave Butler: Many similar issues that I've found as well during my time with provider groups. The EHRs screen can be really busy and ...
  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links